Physician profile
Michael Ehrlich
NPI 1780654186
$12,720.31
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $363 · 2021: $170 · 2022: $299 · 2023: $561 · 2024: $300 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,419 · Honoraria: $4,600 · Food and Beverage: $1,003 · Travel and Lodging: $566 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,418.75 |
| Honoraria | $4,600.00 |
| Food and Beverage | $1,003.16 |
| Travel and Lodging | $565.65 |
| Education | $111.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,874.32 | 2021-2025 | |
| Sk Life Science, INC. | $5,523.42 | 2025 | Xcopri |
| Neurocrine Biosciences, INC. | $398.66 | 2022-2024 | Ingrezza, Ongentys |
| Genzyme Corporation | $350.00 | 2020 | |
| Harmony Biosciences LLC | $218.38 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $189.20 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $73.33 | 2021-2023 | Nuplazid |
| Biogen, INC. | $55.50 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.25 | 2023 | Oxtellar Xr, Trokendi Xr |
| Ucb, INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ehrlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.